Related Experiment Video
Updated: Jun 20, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
Association between mucoid Pseudomonas infection and bronchiectasis in children with cystic fibrosis
Philip M Farrell1, Jannette Collins, Lynn S Broderick
1Department of Pediatrics, University of Wisconsin, Madison, Wis, USA.
Insights
Respiratory infection with mucoid Pseudomonas aeruginosa (PA) significantly correlates with bronchiectasis severity in children with cystic fibrosis. Early eradication of PA is crucial for preventing irreversible lung disease.
Area of Science:
- Pediatric Pulmonology
- Medical Microbiology
- Radiology
Background:
- Cystic fibrosis (CF) is a genetic disorder leading to chronic lung infections and progressive lung damage.
- Bronchiectasis, an irreversible lung condition, is a common complication in children with CF.
- Identifying risk factors for bronchiectasis is critical for timely intervention.
Purpose of the Study:
- To investigate the correlation between bronchiectasis severity in pediatric CF patients and various clinical and microbiological factors.
- To identify specific risk factors contributing to the development of irreversible lung disease in CF.
Main Methods:
- A longitudinal epidemiologic evaluation was conducted on CF patients from a newborn screening trial (1985-2009).
- Thin-section chest computed tomography (CT) was used to objectively assess bronchiectasis severity.
- Respiratory secretions were cultured to differentiate mucoid and nonmucoid Pseudomonas aeruginosa (PA) infections.
Main Results:
- Bronchiectasis was observed in 83% of the studied pediatric CF patients.
- Respiratory infection with mucoid PA was the only significant risk factor correlated with bronchiectasis severity (P = .041).
Conclusions:
- The severity of bronchiectasis in children with CF is significantly associated with mucoid PA respiratory infections.
- Preventive strategies should focus on minimizing exposure to and ensuring early eradication of PA in CF patients.
Purpose:
To correlate the severity of bronchiectasis in children with cystic fibrosis with clinical and microbiologic variables in order to clarify risk factors for the development of irreversible lung disease.
Materials And Methods:
After institutional review board approval and parental informed consents were obtained, a HIPAA-compliant longitudinal epidemiologic evaluation was performed in patients with cystic fibrosis who were enrolled in the Wisconsin trial of newborn screening from 1985 to 2009. Thin-section chest computed tomography (CT) was used in a prospective cross-sectional design to study patients ranging in age from 6.6 to 17.6 years (mean, 11.5 years). Thin-section CT scores were determined objectively on coded images by multiple raters in a standardized fashion. Microbiologic data were obtained by means of culture of respiratory secretions by using methods for differentiation of Pseudomonas aeruginosa (PA) as either nonmucoid or mucoid.
Results:
Eighty-three percent of patients (68 of 82) showed bronchiectasis of varying severity. Of 12 potential risk factors, only respiratory infection with mucoid PA correlated significantly with bronchiectasis (P = .041).
Conclusion:
The severity of bronchiectasis in children with cystic fibrosis is significantly related to respiratory infection with mucoid PA; attempts to prevent bronchiectasis should include reducing exposure to and early eradication of PA.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Microbiota of the Respiratory Tract
Atypical Pneumonia
Pneumonia I: Introduction

